Researchers at the University of Hull and Hull York Medical School are working to drive innovation in healthcare and treatment.
The University of Hull is investing in a ground-breaking research centre to help doctors detect the early signs of three life-changing illnesses.
The Molecular Imaging Research Centre will be used to provide the diagnostic tools to help doctors identify the early signs of cancer, heart disease and dementia.
The £7.2 million centre, being built at Hull’s Castle Hill Hospital, is the result of a partnership between the University, the Daisy Appeal, and Hull and East Yorkshire Hospitals
It builds on the University’s high-calibre research which has resulted in new imaging technologies and inventions which have already instigated six patent applications,
The University of Hull is one of very few universities nationwide to have its own dedicated PET (Positron Emission Tomography) Research Centre.
This state-of-the-art facility uses medical imaging technology for research and the early diagnosis of diseases such as cancer and dementia.